Cart
sales@molnova.com
AMP-945
CAS No. 1393653-34-3
AMP-945( —— )
Catalog No. M28772 CAS No. 1393653-34-3
AMP-945 is a proprietary focal adhesion kinase (FAK) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | Get Quote |
|
| 10MG | 357 | Get Quote |
|
| 25MG | 597 | Get Quote |
|
| 50MG | 851 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAMP-945
-
NoteResearch use only, not for human use.
-
Brief DescriptionAMP-945 is a proprietary focal adhesion kinase (FAK) inhibitor.
-
DescriptionAMP-945 is a proprietary focal adhesion kinase (FAK) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFAK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1393653-34-3
-
Formula Weight527.58
-
Molecular FormulaC28H32F3N5O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (189.54 mM)
-
SMILESCN(CC1)CCC1c(cc1)cc(OC)c1Nc1nc(CCc2c(CC(N)=O)cccc2)c(C(F)(F)F)cn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Michalakea, Eleftheria; Graikou, Konstantia; Aligiannis, Nektarios; Panoutsopoulos, George; Kalpoutzakis, Eleftherios; Roussakis, Christos; Chinou, Ioanna[Phytochemistry Letters, 2019, vol. 31, p. 155 - 160]
molnova catalog
related products
-
FAK activator 1
ZINC40099027 is a specific adhesion plaque kinase (FAK) activator that promotes gastric mucosal repair in persistent aspirin-associated gastric injury through activation of adhesion plaque kinase, activates human adhesion plaque kinase by accelerating the enzyme activity of the structural domain of FAK kinase, activates cytosolic FAK, and promotes intestinal epithelial wound closure.
-
Conteltinib
CT-707 (Conteltinib) is a novel multikinase inhibitor targeting FAK (IC50=1.6 nM).
-
GSK215
GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader (pDC50= 8.4), designed using the FAK inhibitor VS-4718 and a binder for the VHL E3 ligase, capable of inducing rapid and prolonged FAK degradation.
